Literature DB >> 28683567

The NAD+-Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning.

Nathalie Khoury1, Kevin B Koronowski1, Juan I Young2, Miguel A Perez-Pinzon1.   

Abstract

SIGNIFICANCE: Sirtuins are an evolutionarily conserved family of NAD+-dependent lysine deacylases and ADP ribosylases. Their requirement for NAD+ as a cosubstrate allows them to act as metabolic sensors that couple changes in the energy status of the cell to changes in cellular physiological processes. NAD+ levels are affected by several NAD+-producing and NAD+-consuming pathways as well as by cellular respiration. Thus their intracellular levels are highly dynamic and are misregulated in a spectrum of metabolic disorders including cerebral ischemia. This, in turn, compromises several NAD+-dependent processes that may ultimately lead to cell death. Recent Advances: A number of efforts have been made to replenish NAD+ in cerebral ischemic injuries as well as to understand the functions of one its important mediators, the sirtuin family of proteins through the use of pharmacological modulators or genetic manipulation approaches either before or after the insult. Critical Issues and Future Directions: The results of these studies have regarded the sirtuins as promising therapeutic targets for cerebral ischemia. Yet, additional efforts are needed to understand the role of some of the less characterized members and to address the sex-specific effects observed with some members. Sirtuins also exhibit cell-type-specific expression in the brain as well as distinct subcellular and regional localizations. As such, they are involved in diverse and sometimes opposing cellular processes that can either promote neuroprotection or further contribute to the injury; which also stresses the need for the development and use of sirtuin-specific pharmacological modulators. Antioxid. Redox Signal. 28, 691-710.

Entities:  

Keywords:  NAD+; SIRT; cerebral ischemia; cerebral ischemic tolerance; preconditioning; sirtuins

Mesh:

Substances:

Year:  2017        PMID: 28683567      PMCID: PMC5824497          DOI: 10.1089/ars.2017.7258

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  189 in total

1.  Resveratrol protects primary cortical neuron cultures from transient oxygen-glucose deprivation by inhibiting MMP-9.

Authors:  Dakuan Gao; Tao Huang; Xiaofan Jiang; Shijie Hu; Lei Zhang; Zhou Fei
Journal:  Mol Med Rep       Date:  2014-03-28       Impact factor: 2.952

2.  An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: gender-dependent effect.

Authors:  Mohammad Reza Amiri-Nikpour; Surena Nazarbaghi; Milad Hamdi-Holasou; Yousef Rezaei
Journal:  Acta Neurol Scand       Date:  2014-08-23       Impact factor: 3.209

3.  Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney.

Authors:  Shinji Kume; Takashi Uzu; Kihachiro Horiike; Masami Chin-Kanasaki; Keiji Isshiki; Shin-Ichi Araki; Toshiro Sugimoto; Masakazu Haneda; Atsunori Kashiwagi; Daisuke Koya
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

4.  The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms.

Authors:  M Kaeberlein; M McVey; L Guarente
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

5.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

6.  Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation.

Authors:  Ting Wang; Jun Gu; Peng-Fei Wu; Fang Wang; Zhe Xiong; Yuan-Jian Yang; Wen-Ning Wu; Ling-Dan Dong; Jian-Guo Chen
Journal:  Free Radic Biol Med       Date:  2009-03-09       Impact factor: 7.376

Review 7.  Evaluating the role of niacin in human carcinogenesis.

Authors:  E L Jacobson; A J Dame; J S Pyrek; M K Jacobson
Journal:  Biochimie       Date:  1995       Impact factor: 4.079

Review 8.  Sorting out functions of sirtuins in cancer.

Authors:  M Roth; W Y Chen
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

9.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

Authors:  Rui-Hong Wang; Kundan Sengupta; Cuiling Li; Hyun-Seok Kim; Liu Cao; Cuiying Xiao; Sangsoo Kim; Xiaoling Xu; Yin Zheng; Beverly Chilton; Rong Jia; Zhi-Ming Zheng; Ettore Appella; Xin Wei Wang; Thomas Ried; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743

Review 10.  NAD(+) metabolism: Bioenergetics, signaling and manipulation for therapy.

Authors:  Yue Yang; Anthony A Sauve
Journal:  Biochim Biophys Acta       Date:  2016-06-29
View more
  17 in total

1.  SIRT1 Decreases Emotional Pain Vulnerability with Associated CaMKIIα Deacetylation in Central Amygdala.

Authors:  Chenghua Zhou; Yuqing Wu; Xiaobao Ding; Naihao Shi; Youqin Cai; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2020-01-31       Impact factor: 6.167

2.  Ischemic Neuroprotectant PKCε Restores Mitochondrial Glutamate Oxaloacetate Transaminase in the Neuronal NADH Shuttle after Ischemic Injury.

Authors:  Jing Xu; Nathalie Khoury; Charles W Jackson; Iris Escobar; Samuel D Stegelmann; Kunjan R Dave; Miguel A Perez-Pinzon
Journal:  Transl Stroke Res       Date:  2019-08-31       Impact factor: 6.829

3.  Preconditioning with partial caloric restriction confers long-term protection against grey and white matter injury after transient focal ischemia.

Authors:  Jia Zhang; Wenting Zhang; Xuguang Gao; Yongfang Zhao; Di Chen; Na Xu; Hongjian Pu; R Anne Stetler; Yanqin Gao
Journal:  J Cereb Blood Flow Metab       Date:  2018-07-04       Impact factor: 6.200

Review 4.  Role of NAD+ and FAD in Ischemic Stroke Pathophysiology: An Epigenetic Nexus and Expanding Therapeutic Repertoire.

Authors:  Parimala Narne; Prakash Babu Phanithi
Journal:  Cell Mol Neurobiol       Date:  2022-09-30       Impact factor: 4.231

Review 5.  Research Progress on the Role of Sirtuin 1 in Cerebral Ischemia.

Authors:  Yijia Fangma; Haitong Wan; Chongyu Shao; Liang Jin; Yu He
Journal:  Cell Mol Neurobiol       Date:  2022-09-24       Impact factor: 4.231

6.  SIRT1 rs7896005 polymorphism affects major vascular outcomes, not all-cause mortality, in Caucasians with type 2 diabetes: A 13-year observational study.

Authors:  Angela Dardano; Daniela Lucchesi; Monia Garofolo; Elisa Gualdani; Pierpaolo Falcetta; Veronica Sancho Bornez; Paolo Francesconi; Stefano Del Prato; Giuseppe Penno
Journal:  Diabetes Metab Res Rev       Date:  2022-02-07       Impact factor: 8.128

Review 7.  Brain SIRT1 Mediates Metabolic Homeostasis and Neuroprotection.

Authors:  Jing Xu; Charlie W Jackson; Nathalie Khoury; Iris Escobar; Miguel A Perez-Pinzon
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-23       Impact factor: 5.555

8.  SIRT1 activation with neuroheal is neuroprotective but SIRT2 inhibition with AK7 is detrimental for disconnected motoneurons.

Authors:  David Romeo-Guitart; Tatiana Leiva-Rodríguez; María Espinosa-Alcantud; Núria Sima; Alejandro Vaquero; Helena Domínguez-Martín; Diego Ruano; Caty Casas
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

Review 9.  Effects of ischemic preconditioning on mitochondrial and metabolic neruoprotection: 5' adenosine monophosphate-activated protein kinase and sirtuins.

Authors:  Charles W Jackson; Iris Escobar; Jing Xu; Miguel A Perez-Pinzon
Journal:  Brain Circ       Date:  2018-06-29

10.  SIRT1 mediates hypoxic preconditioning induced attenuation of neurovascular dysfunction following subarachnoid hemorrhage.

Authors:  Ananth K Vellimana; Diane J Aum; Deepti Diwan; Julian V Clarke; James W Nelson; Molly Lawrence; Byung Hee Han; Jeffrey M Gidday; Gregory J Zipfel
Journal:  Exp Neurol       Date:  2020-10-01       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.